Pituitary prolactinoma is a benign tumor originating from the anterior pituitary gland, characterized primarily by excessive secretion of prolactin (PRL). Such tumors can be microadenomas (less than 1 cm in diameter) or macroadenomas (greater than 1 cm in diameter), and they do have the potential to enlarge, although their growth rate is generally slow. The growth rate of a pituitary prolactinoma is closely related to the patient's symptoms, the timing of treatment, and the treatment modality chosen.

Can pituitary prolactinoma grow larger?

I. Growth Characteristics of Pituitary Prolactinoma

The growth rate of pituitary prolactinoma varies from person to person. In some cases, the tumor may remain largely unchanged for many years, while in others it may enlarge over a relatively short period. This variability is related to the tumor's biological characteristics, individual differences, and whether appropriate treatment is received. Untreated prolactinomas may gradually increase in size, leading to compression of surrounding structures.

II. Symptoms That May Occur as the Tumor Enlarges 

The pituitary gland is located at the base of the brain, adjacent to important neural structures such as the optic chiasm, cavernous sinus, and hypothalamus. As a prolactinoma enlarges, it may compress these structures, causing the following symptoms:

1. Visual problems: Compression of the optic chiasm can lead to visual field defects, such as bitemporal hemianopia (loss of peripheral vision on both sides). As the tumor continues to grow, visual disturbances may worsen.

2. Headache: Tumor compression of surrounding tissues or impairment of cerebrospinal fluid circulation may cause headache.

3. Endocrine disorders: In addition to abnormal prolactin levels, the tumor may interfere with the secretion of other pituitary hormones, such as adrenocorticotropic hormone (ACTH), thyroid‑stimulating hormone (TSH), growth hormone (GH), and gonadotropins (FSH and LH), thereby triggering various metabolic and reproductive system issues.

4. Pituitary apoplexy: As the tumor enlarges, its blood supply may be compromised, leading to internal hemorrhage or infarction within the tumor—a condition known as pituitary apoplexy, which can suddenly exacerbate the above symptoms.

III. Indications for Surgery

Although the primary treatment for pituitary prolactinoma is usually medical therapy, particularly with dopamine receptor agonists to lower prolactin levels and shrink the tumor, surgery may become necessary in certain circumstances. Surgical indications include:

1. Medical therapy is ineffective or not tolerated.

2. Presence of severe visual impairment or other compressive symptoms.

3. Rapid enlargement of the tumor volume, especially as observed on imaging studies.

4. Risk of pituitary apoplexy.

5. The patient wishes to preserve fertility, but medical therapy adversely affects gonadal function.

IV. Size Criteria for Surgical Indications

There is no absolute numerical size criterion for surgery in pituitary prolactinoma; rather, the decision is based on a comprehensive evaluation. In general, if the prolactinoma causes the above‑mentioned compressive symptoms, or if the tumor has grown to a clinically significant extent, surgery may be considered even at the microadenoma stage. In some cases, even for macroadenomas larger than 1 cm in diameter, surgery may be deferred if medical therapy is effective and there are no compressive symptoms.

Can pituitary prolactinoma grow larger?

In summary, pituitary prolactinoma is a tumor resulting from abnormal proliferation of pituitary gland cells, and sustained elevated prolactin levels can stimulate tumor growth. Although some small pituitary tumors may remain stable or even shrink over time, without timely treatment, the tumor may still gradually enlarge. The growth rate varies among individuals, depending on tumor size, serum prolactin levels, and other personal factors. Therefore, regular monitoring of tumor size and hormone levels is essential for patients diagnosed with prolactinoma.

The growth rate of pituitary prolactinoma and its impact on symptoms are highly individualized. Early diagnosis and treatment are crucial to prevent tumor enlargement and related complications. Medical therapy is usually the first‑line treatment, but surgery may become necessary in specific situations. Patients should work closely with endocrinology specialists to develop an optimal treatment plan based on the tumor's dynamic changes and their personal health status.

Note: INC International Neurosurgeon Circle's International Neurosurgical Advisory Group (WANG) includes many internationally renowned professors with superb surgical skills and extensive successful case experience, such as Professor Sébastien Froelich (France), former Chairman of the Skull Base Surgery Committee of the World Federation of Neurosurgical Societies (WFNS). He specializes in endoscopic endonasal resection of skull base tumors, performing minimally invasive surgeries via neuroendoscopy for complex brain tumors including chordomas, craniopharyngiomas, and pituitary adenomas. His "chopsticks" technique in endoscopic surgery not only improves the tumor resection rate but also leads to better prognoses for tumor patients.

The above full text is for reference only and does not constitute medical advice. For more information about pituitary adenomas, please contact us. Also, please follow INC's official website and official public accounts. As a bridge connecting neurosurgical experts between China and other countries, INC International Neurosurgeon Circle has, in recent years, organized visits by international professors to China for academic exchanges, technological discussions, and high‑difficulty surgeries; it has also cooperated with multiple domestic hospitals to promote the common development of neurosurgery both domestically and internationally, providing more new treatment options for neurosurgical patients worldwide.